JP2024515902A5 - - Google Patents

Info

Publication number
JP2024515902A5
JP2024515902A5 JP2024508819A JP2024508819A JP2024515902A5 JP 2024515902 A5 JP2024515902 A5 JP 2024515902A5 JP 2024508819 A JP2024508819 A JP 2024508819A JP 2024508819 A JP2024508819 A JP 2024508819A JP 2024515902 A5 JP2024515902 A5 JP 2024515902A5
Authority
JP
Japan
Prior art keywords
seq
aav
polypeptide
amino acid
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515902A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/053775 external-priority patent/WO2022229807A1/en
Publication of JP2024515902A publication Critical patent/JP2024515902A/ja
Publication of JP2024515902A5 publication Critical patent/JP2024515902A5/ja
Pending legal-status Critical Current

Links

JP2024508819A 2021-04-26 2022-04-22 組織向性が改善されたアデノ随伴ウイルスベクターカプシド Pending JP2024515902A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163179968P 2021-04-26 2021-04-26
US63/179,968 2021-04-26
PCT/IB2022/053775 WO2022229807A1 (en) 2021-04-26 2022-04-22 Adeno-associated viral vector capsids with improved tissue tropism

Publications (2)

Publication Number Publication Date
JP2024515902A JP2024515902A (ja) 2024-04-10
JP2024515902A5 true JP2024515902A5 (enExample) 2025-05-01

Family

ID=81579930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508819A Pending JP2024515902A (ja) 2021-04-26 2022-04-22 組織向性が改善されたアデノ随伴ウイルスベクターカプシド

Country Status (6)

Country Link
US (1) US20250188126A1 (enExample)
EP (1) EP4329820A1 (enExample)
JP (1) JP2024515902A (enExample)
CN (1) CN117377500A (enExample)
CA (1) CA3216420A1 (enExample)
WO (1) WO2022229807A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230004719A (ko) 2020-04-20 2023-01-06 테나야 테라퓨틱스, 인코포레이티드 조작된 캡시드를 갖는 아데노-연관 바이러스
CN119569834A (zh) * 2023-09-06 2025-03-07 北京锦篮基因科技有限公司 靶向心肌细胞的aav衣壳蛋白变体及其用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2221293C (en) 1995-06-07 2012-09-18 University Of North Carolina At Chapel Hill Helper virus-free aav production
AU723497C (en) 1996-09-06 2001-10-11 Trustees Of The University Of Pennsylvania, The Method for recombinant adeno-associated virus-directed gene therapy
CA2265460A1 (en) 1996-09-11 1998-03-19 The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services Aav4 vector and uses thereof
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
AU762220B2 (en) 1998-05-28 2003-06-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The AAV5 vector and uses thereof
EP1127150B1 (en) 1998-11-05 2007-05-16 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
ATE454445T1 (de) 1998-11-10 2010-01-15 Univ North Carolina Virusvektoren und verfahren für ihre herstellung und verabreichung.
HUE054805T2 (hu) 2003-09-30 2021-09-28 Univ Pennsylvania Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
CA2853482C (en) 2011-10-28 2020-05-19 Joshua Grieger Cell line for production of adeno-associated virus
CN105247044B (zh) 2013-05-31 2021-05-07 加利福尼亚大学董事会 腺相关病毒变体及其使用方法
PT3024498T (pt) 2013-07-22 2020-03-06 Childrens Hospital Philadelphia Variante aav e composições, métodos e usos para transferência genética em células, órgãos e tecidos
GB201403684D0 (en) 2014-03-03 2014-04-16 King S College London Vector
PT3313991T (pt) 2015-06-23 2024-09-27 Childrens Hospital Philadelphia Fator ix modificado e composições, métodos e utilizações para transferência de genes para células, órgãos e tecidos
CN112004820B (zh) * 2018-03-30 2023-09-12 利兰斯坦福初级大学董事会 具有增强的人胰腺向性的新型重组腺相关病毒衣壳
EP3793615A2 (en) * 2018-05-16 2021-03-24 Voyager Therapeutics, Inc. Directed evolution of aav to improve tropism for cns

Similar Documents

Publication Publication Date Title
US11338045B2 (en) Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
US20230048025A1 (en) Adeno associated viral vectors
CN119613504A (zh) 腺相关病毒变异衣壳和其使用方法
JP2024514956A (ja) 組織標的化された改変aavカプシドおよびその使用方法
AU2020331882B2 (en) Isolated modified VP1 capsid protein of AAV5
US20150315610A1 (en) Aav variant
CN113316639A (zh) 用于治疗庞贝氏病的治疗性腺相关病毒
JP2003526377A (ja) キメラキャプシドベクターの製造
US20250297285A1 (en) Transgene cassettes designed to express a human mecp2 gene
EP4159863A1 (en) Codon-optimized nucleic acid encoding smn1 protein
JP2021531044A5 (enExample)
JP7641911B2 (ja) 新型の酵素組成物
CN117377500A (zh) 具有改善的组织向性的腺相关病毒载体衣壳
RU2822884C1 (ru) Мини-белок ush2a, нуклеиновая кислота, кодирующая минибелок ush2a, и содержащий ее экспрессионный вектор для генной терапии
RU2825667C2 (ru) Выделенный модифицированный белок VPI капсида аденоассоциированного вируса 9 серотипа (AAV9), капсид и вектор на его основе
RU2809389C2 (ru) Мутант aav, обладающий способностью нацеливаться на головной мозг
AU2024298945A1 (en) Brain-tropic aav mutant
CA3299376A1 (en) Brain-tropic aav mutant
CN121758632A (zh) 靶向肌肉的腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用
OA21075A (en) Codon-optimized nucleic acid that encodes SMN1 protein, and use thereof
HK40075924A (en) Isolated modified vp1 capsid protein of aav5
HK40075924B (zh) Aav5的分离的修饰的vp1衣壳蛋白
RU2021124726A (ru) Выделенный модифицированный белок VPI капсида аденоассоциированного вируса 9 серотипа (AAV9), капсид и вектор на его основе
HK40062349B (zh) 具有脑靶向特性的aav突变体
HK40059690A (en) Therapeutic adeno-associated virus for treating pompe disease